• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与人类甲状腺激素受体β配体结合域突变相关的全身性甲状腺激素抵抗。

Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta.

作者信息

Sakurai A, Takeda K, Ain K, Ceccarelli P, Nakai A, Seino S, Bell G I, Refetoff S, DeGroot L J

机构信息

Thyroid Study Unit, University of Chicago, IL 60637.

出版信息

Proc Natl Acad Sci U S A. 1989 Nov;86(22):8977-81. doi: 10.1073/pnas.86.22.8977.

DOI:10.1073/pnas.86.22.8977
PMID:2510172
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC298414/
Abstract

The syndrome of generalized resistance to thyroid hormone is characterized by elevated circulating levels of thyroid hormone in the presence of an overall eumetabolic state and failure to respond normally to triiodothyronine. We have evaluated a family with inherited generalized resistance to thyroid hormone for abnormalities in the thyroid hormone nuclear receptors. A single guanine----cytosine replacement in the codon for amino acid 340 resulted in a glycine----arginine substitution in the hormone-binding domain of one of two alleles of the patient's thyroid hormone nuclear receptor beta gene. In vitro translation products of this mutant human thyroid hormone nuclear receptor beta gene did not bind triiodothyronine. Thus, generalized resistance to thyroid hormone can result from expression of an abnormal thyroid hormone nuclear receptor molecule.

摘要

全身性甲状腺激素抵抗综合征的特征是,在整体代谢正常的状态下循环甲状腺激素水平升高,且对三碘甲状腺原氨酸不能正常反应。我们评估了一个遗传性全身性甲状腺激素抵抗的家族,以检测其甲状腺激素核受体的异常情况。患者甲状腺激素核受体β基因的两个等位基因之一,其第340位密码子中的单个鸟嘌呤-胞嘧啶替换,导致激素结合域中的甘氨酸-精氨酸替换。该突变型人类甲状腺激素核受体β基因的体外翻译产物不能结合三碘甲状腺原氨酸。因此,全身性甲状腺激素抵抗可能是由异常甲状腺激素核受体分子的表达所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aec/298414/f59c92806ad4/pnas00289-0395-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aec/298414/7c37a4639b2a/pnas00289-0395-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aec/298414/09ed32b6ca93/pnas00289-0395-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aec/298414/f59c92806ad4/pnas00289-0395-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aec/298414/7c37a4639b2a/pnas00289-0395-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aec/298414/09ed32b6ca93/pnas00289-0395-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aec/298414/f59c92806ad4/pnas00289-0395-c.jpg

相似文献

1
Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta.与人类甲状腺激素受体β配体结合域突变相关的全身性甲状腺激素抵抗。
Proc Natl Acad Sci U S A. 1989 Nov;86(22):8977-81. doi: 10.1073/pnas.86.22.8977.
2
Mild resistance to thyroid hormone with a truncated thyroid hormone receptor beta.因甲状腺激素受体β截短导致的轻度甲状腺激素抵抗
Exp Clin Endocrinol Diabetes. 1996;104(4):339-43. doi: 10.1055/s-0029-1211464.
3
A point mutation in the 3,5,3'-triiodothyronine-binding domain of thyroid hormone receptor-beta associated with a family with generalized resistance to thyroid hormone.甲状腺激素受体β的3,5,3'-三碘甲状腺原氨酸结合域中的一个点突变,与一个全身性甲状腺激素抵抗家族相关。
J Clin Endocrinol Metab. 1992 Jul;75(1):213-7. doi: 10.1210/jcem.75.1.1619012.
4
Functional properties of a novel mutant thyroid hormone receptor in a family with generalized thyroid hormone resistance syndrome.一个患有全身性甲状腺激素抵抗综合征的家族中新型突变甲状腺激素受体的功能特性
Clin Endocrinol (Oxf). 1992 Mar;36(3):281-9. doi: 10.1111/j.1365-2265.1992.tb01444.x.
5
A new point mutation in the 3,5,3'-triiodothyronine-binding domain of the c-erbA beta thyroid hormone receptor is tightly linked to generalized thyroid hormone resistance.c-erbAβ甲状腺激素受体的3,5,3'-三碘甲状腺原氨酸结合域中的一个新的点突变与全身性甲状腺激素抵抗紧密相关。
J Clin Endocrinol Metab. 1991 Jan;72(1):32-8. doi: 10.1210/jcem-72-1-32.
6
A homozygous deletion in the c-erbA beta thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor.一名全身性甲状腺激素抵抗患者的c-erbAβ甲状腺激素受体基因纯合缺失:突变受体的分离与鉴定
Mol Endocrinol. 1991 Mar;5(3):327-35. doi: 10.1210/mend-5-3-327.
7
A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.一个患有全身性甲状腺激素抵抗的家族中C-erbAβ甲状腺激素受体的碱基突变。另外两个家族中的分子异质性。
J Clin Invest. 1990 Jan;85(1):93-100. doi: 10.1172/JCI114438.
8
Pituitary resistance to thyroid hormone associated with a base mutation in the hormone-binding domain of the human 3,5,3'-triiodothyronine receptor-beta.垂体对甲状腺激素抵抗与人类3,5,3'-三碘甲状腺原氨酸受体β激素结合域的碱基突变有关。
J Clin Endocrinol Metab. 1993 May;76(5):1254-8. doi: 10.1210/jcem.76.5.8496318.
9
An arginine to histidine mutation in codon 315 of the c-erbA beta thyroid hormone receptor in a kindred with generalized resistance to thyroid hormones results in a receptor with significant 3,5,3'-triiodothyronine binding activity.在一个对甲状腺激素普遍抵抗的家族中,c-erbAβ甲状腺激素受体密码子315处的精氨酸突变为组氨酸,导致该受体具有显著的3,5,3'-三碘甲状腺原氨酸结合活性。
J Clin Endocrinol Metab. 1992 May;74(5):1164-70. doi: 10.1210/jcem.74.5.1314846.
10
Two consecutive nucleotide substitutions resulting in the T3 receptor beta gene resulting in an 11-amino acid truncation in a patient with generalized resistance to thyroid hormone.在一名对甲状腺激素普遍抵抗的患者中,导致甲状腺激素受体β基因出现两个连续核苷酸取代,进而造成11个氨基酸截短。
Mol Cell Endocrinol. 1995 Oct 30;114(1-2):9-17. doi: 10.1016/0303-7207(95)03636-l.

引用本文的文献

1
TRα1 mutant suppresses KLF9 to cause endometrial metaplasia with ectopic IL-33 expression leading to uterine fibrosis and infertility.TRα1突变体抑制KLF9,导致子宫内膜化生并伴有异位IL-33表达,进而引发子宫纤维化和不孕。
Sci Rep. 2025 Jan 31;15(1):3892. doi: 10.1038/s41598-025-86848-5.
2
Effects of RARα ligand binding domain mutations on breast fibroepithelial tumor function and signaling.维甲酸受体α(RARα)配体结合域突变对乳腺纤维上皮肿瘤功能及信号传导的影响
NPJ Breast Cancer. 2025 Jan 3;11(1):1. doi: 10.1038/s41523-024-00716-5.
3
Thyroid Hormone Receptors as Tumor Suppressors in Cancer.

本文引用的文献

1
Growth hormone gene transcription is regulated by thyroid and glucocorticoid hormones in cultured rat pituitary tumor cells.在培养的大鼠垂体肿瘤细胞中,生长激素基因转录受甲状腺激素和糖皮质激素的调节。
J Biol Chem. 1982 Oct 10;257(19):11627-32.
2
Inappropriate secretion of thyroid-stimulating hormone.促甲状腺激素分泌不当。
Ann Intern Med. 1981 Sep;95(3):339-51. doi: 10.7326/0003-4819-95-3-339.
3
The consequences of inappropriate treatment because of failure to recognize the syndrome of pituitary and peripheral tissue resistance to thyroid hormone.
甲状腺激素受体作为癌症中的肿瘤抑制因子。
Endocrinology. 2024 Aug 27;165(10). doi: 10.1210/endocr/bqae115.
4
Pathogenesis of cancers derived from thyroid follicular cells.甲状腺滤泡细胞来源癌的发病机制。
Nat Rev Cancer. 2023 Sep;23(9):631-650. doi: 10.1038/s41568-023-00598-y. Epub 2023 Jul 12.
5
A New Mechanism in THRA Resistance: The First Disease-Associated Variant Leading to an Increased Inhibitory Function of THRA2.甲状腺激素受体α(THRA)抵抗的一种新机制:首个与疾病相关的导致THRA2抑制功能增强的变体
Int J Mol Sci. 2021 May 19;22(10):5338. doi: 10.3390/ijms22105338.
6
Resistance to Thyroid Hormone Beta: A Focused Review.抗甲状腺激素β受体:专题述评。
Front Endocrinol (Lausanne). 2021 Mar 31;12:656551. doi: 10.3389/fendo.2021.656551. eCollection 2021.
7
Resistance to thyroid hormone caused by heterozygous mutation of thyroid hormone receptor B gene c.G1378A: Report of one Chinese pedigree and literature review.甲状腺激素受体B基因c.G1378A杂合突变所致甲状腺激素抵抗:1个中国家系报告及文献复习
Clin Case Rep. 2021 Feb 8;9(3):1055-1059. doi: 10.1002/ccr3.3497. eCollection 2021 Mar.
8
Familial Dysalbuminemic Hyperthyroxinemia: An Underdiagnosed Entity.家族性异常白蛋白血症性高甲状腺素血症:一种诊断不足的疾病。
J Clin Med. 2020 Jul 3;9(7):2105. doi: 10.3390/jcm9072105.
9
The Clinical Spectrum of Resistance to Thyroid Hormone Alpha in Children and Adults.儿童和成人甲状腺激素α抵抗的临床谱。
J Clin Res Pediatr Endocrinol. 2021 Feb 26;13(1):1-14. doi: 10.4274/jcrpe.galenos.2020.2019.0190. Epub 2020 Apr 29.
10
Insight Into Molecular Determinants of T3 vs T4 Recognition From Mutations in Thyroid Hormone Receptor α and β.从甲状腺激素受体 α 和 β 的突变中洞察 T3 与 T4 的识别的分子决定因素。
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3491-3500. doi: 10.1210/jc.2018-02794.
由于未能识别垂体和外周组织对甲状腺激素抵抗综合征而导致的不适当治疗的后果。
Metabolism. 1983 Aug;32(8):822-34. doi: 10.1016/0026-0495(83)90114-2.
4
Radioimmunoassays specific for the tertiary and primary structures of thyroxine-binding globulin (TBG): measurement of denatured TBG in serum.针对甲状腺素结合球蛋白(TBG)三级和一级结构的放射免疫测定:血清中变性TBG的测量。
J Clin Endocrinol Metab. 1984 Aug;59(2):269-77. doi: 10.1210/jcem-59-2-269.
5
Polymorphic DNA region adjacent to the 5' end of the human insulin gene.人类胰岛素基因5'端相邻的多态性DNA区域。
Proc Natl Acad Sci U S A. 1981 Sep;78(9):5759-63. doi: 10.1073/pnas.78.9.5759.
6
Thyroid hormone resistance.甲状腺激素抵抗
Ann Clin Res. 1980 Oct;12(5):243-53.
7
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing.利用单链噬菌体克隆辅助快速DNA测序。
J Mol Biol. 1980 Oct 25;143(2):161-78. doi: 10.1016/0022-2836(80)90196-5.
8
Elevated serum thyroglobulin level in congenital thyroxine-binding globulin deficiency.先天性甲状腺素结合球蛋白缺乏症患者血清甲状腺球蛋白水平升高。
J Clin Endocrinol Metab. 1983 Sep;57(3):665-7. doi: 10.1210/jcem-57-3-665.
9
Studies of a sibship with apparent hereditary resistance to the intracellular action of thyroid hormone.对一个家系进行的研究,该家系对甲状腺激素的细胞内作用表现出明显的遗传性抗性。
Metabolism. 1972 Aug;21(8):723-56. doi: 10.1016/0026-0495(72)90121-7.
10
Serum tests for measurement of thyroid function.用于测量甲状腺功能的血清检测。
Hormones. 1971;2(5):266-79. doi: 10.1159/000178240.